Patient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapy ...

• Main Authors: Sælen, Marie G., Hjelle, Line V., Aarsæther, Erling, Knutsen, Tore, Andersen, Sigve, Bentzen, Anne G., Richardsen, Elin, Fosså, Sophie D., Haugnes, Hege S.
• Format: Dataset
• Language: unknown
• Published: Taylor & Francis 2023
• Subjects: Medicine; Cell Biology; Pharmacology; Biotechnology; Chemical Sciences not elsewhere classified; Sociology; FOS Sociology; Immunology; FOS Clinical medicine; Cancer; Norway; North Norway
• Online Access: https://dx.doi.org/10.6084/m9.figshare.23574104; https://tandf.figshare.com/articles/dataset/Patient-reported_outcomes_after_curative_treatment_for_prostate_cancer_with_prostatectomy_primary_radiotherapy_or_salvage_radiotherapy/23574104

Trials reporting adverse health outcomes (AHOs) in terms of patient-reported outcome measures (PROMs) after contemporary curative treatment of prostate cancer (PC) are hampered by study heterogeneity and lack of new treatment techniques. Particularly, the evidence regarding toxicities after radiotherapy (RT) with the volumetric arc therapy (VMAT) technique is limited, and comparisons between men treated with surgery, primary radiotherapy (PRT) and salvage radiotherapy (SRT) are lacking. The aim of the study was to evaluate change in PROMs 3 months after treatment with robotic-assisted laparoscopic prostatectomy (RALP), PRT and SRT administered with VMAT. A prospective cohort study of men with PC who received curative treatment at the University Hospital of North Norway between 2012 and 2017 for RALP and between 2016 and 2021 for radiotherapy was conducted. A cohort of 787 men were included; 406 men treated with RALP, 265 received PRT and 116 received SRT. Patients completed the validated PROM instrument ...